2BBBullish & Bearish
Penumbra, Inc. Common Stock (PEN) trades on NYSE. It operates in the Health Care sector, Medical Devices industry. Its current 2BB score is 65 out of 100.
Penumbra, Inc. is an American medical device company headquartered in Alameda, California. The company was founded by Arani Bose and Adam Elsesser in 2004. It manufactures devices for interventional therapies to treat vascular conditions such as stroke and aneurysm. In January 2026, Boston Scientific announced it would acquire Penumbra in a $15 billion cash and stock deal. The deal was expected to close by year-end.
Penumbra, Inc. Common Stock’s current 2BB score is 65 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 66 | High |
| Momentum | 47 | Stable |
| Financial strength | 80 | Strong |
| Quality | 100 | Very Strong |
| Risk | 28 | Low |
| CEO | Adam Elsesser |
| Founded | 2004 |
| Employees | 4.7K |
| P/E ratio | 78.84 |
| 52-week range | $221.26 – $362.41 |
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2026-11-03 | — | 1.2902 | — | $406.08M |
| 2026-08-04 | — | 1.1987 | — | $392.90M |
| 2026-05-06 | 0.82 | 1.0859 | $374.76M | $374.82M |
| 2026-02-25 | 1.18 | 1.1236 | $385.38M | $370.46M |